摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氯-N-[(4-氯苯基)磺酰基]-苯磺酰胺 | 2725-55-5

中文名称
4-氯-N-[(4-氯苯基)磺酰基]-苯磺酰胺
中文别名
——
英文名称
di(4-chlorobenzenesulfonyl)amine
英文别名
4-chloro-N-((4-chlorophenyl)sulfonyl)benzenesulfonamide;4,4'-Dichlorodiphenyldisulfimide;4-chloro-N-(4-chlorophenyl)sulfonylbenzenesulfonamide
4-氯-N-[(4-氯苯基)磺酰基]-苯磺酰胺化学式
CAS
2725-55-5
化学式
C12H9Cl2NO4S2
mdl
——
分子量
366.246
InChiKey
ISLGMFCNZJGDTA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    521.1±60.0 °C(Predicted)
  • 密度:
    1.567±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    97.1
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2935009090

SDS

SDS:8b5d0990106465e9baf9b1c3e9176ec5
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 4,4'-DICHLORODIPHENYLDISULFIMIDE
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 2725-55-5
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Eye irritation (Category 2), H319
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xi Irritant R36
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H319 Causes serious eye irritation.
Precautionary statement(s)
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Formula : C12H9Cl2NO4S2
Molecular Weight : 366,24 g/mol
CAS-No. : 2725-55-5
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
4,4'-DICHLORODIPHENYLDISULFIMIDE
Eye Irrit. 2; H319 -
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 3,354
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氯-N-[(4-氯苯基)磺酰基]-苯磺酰胺 在 sodium hydroxide 、 fluorine 作用下, 以 乙腈 为溶剂, 反应 1.0h, 以47%的产率得到4-chloro-N-((4-chlorophenyl)-sulfonyl)-N-fluorobenzenesulfonamide
    参考文献:
    名称:
    结构微调N-氟苯磺酰胺对2-羟吲哚的对映选择性氟化
    摘要:
    我们描述了我们通过改变苯环上的取代基来微调 N-氟苯磺酰胺在氟化反应中的反应性和选择性的尝试。制备了一系列在邻位、间位和对位带有取代基的 N-氟苯磺酰胺,并将其用于手性钯配合物催化的 2-羟吲哚的对映选择性氟化。氟化试剂 1b、1c、1d、1e、1h、1i 和 1j 的结果与 1a 相似,而 1f、1g 和 1n 的产率和选择性较差。在温和的反应条件下,使用 N-氟-4,4'-二氟-苯磺酰胺作为原料,以优异的产率(高达 98%)和对映选择性(高达 99%ee)获得了一系列 3-氟-2-羟吲哚氟化剂。
    DOI:
    10.1002/ejoc.201402072
  • 作为产物:
    参考文献:
    名称:
    Runge et al., Chemische Berichte, 1953, vol. 86, p. 1571,1573
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Compounds and compositons for treating C1s-mediated diseases and conditions
    申请人:3-Dimensional Pharmaceuticals, Inc.
    公开号:US20020037915A1
    公开(公告)日:2002-03-28
    Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula I 1 or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R 1 , R 2 , R 3 , R 4 , X, Y and Z are defined in the specification.
    揭示了一种治疗急性或慢性疾病症状的方法,该疾病是由补体级联的经典途径介导的,包括向需要此类治疗的哺乳动物施用化合物I的治疗有效量或其溶剂化合物、水合物或药用可接受盐;其中规范中定义了R1、R2、R3、R4、X、Y和Z。
  • A Novel Synthesis of N-Sulfonylformamidines from N-Sulfonyl­sulfonamides
    作者:Hakjune Rhee、Yuri Jeong、Jaeyoung Ban、Minkyung Lim
    DOI:10.1055/s-0036-1591936
    日期:2018.5
    p-toluenesulfonyl chloride (TsCl) and N,N -disubstituted formamides. In this reaction, it was expected that mixing TsCl with the N,N-disubstituted formamide would generate an iminium salt (Vilsmeier reagent). The reaction avoids the use of metal catalysts and hazardous reagents, and the desired N-sulfonylformamidines were obtained in 60% to quantitative yields. N-Sulfonylformamidines were synthesized from N-sulfonylsulfonamides
    ‡这些作者对这项工作做出了同等的贡献 抽象的 Ñ -Sulfonylformamidines从合成Ñ -sulfonylsulfonamides通过与反应p甲苯磺酰氯(的TsCl)和Ñ,ñ -二取代的甲酰胺。在该反应中,预期将TsCl与N,N-二取代的甲酰胺混合将产生亚胺盐(Vilsmeier试剂)。该反应避免了使用金属催化剂和有害试剂,并且以60%至定量收率获得了所需的N-磺酰基甲am。 Ñ -Sulfonylformamidines从合成Ñ -sulfonylsulfonamides通过与反应p甲苯磺酰氯(的TsCl)和Ñ,ñ -二取代的甲酰胺。在该反应中,预期将TsCl与N,N-二取代的甲酰胺混合将产生亚胺盐(Vilsmeier试剂)。该反应避免了使用金属催化剂和有害试剂,并且以60%至定量收率获得了所需的N-磺酰基甲am。
  • Effects of Medium and Substituents on Dissociationof 4,4'-Disubstituted Bis(benzenesulfon)imides
    作者:Miroslav Ludwig、Pavel Štverka
    DOI:10.1135/cccc19961205
    日期:——

    Ten 4,4'-disubstituted bis(arenesulfon)imides of the general formula XC6H4SO2NHSO2C6H4X have been synthesized and their structures confirmed by their 1H NMR spectra. Elemental analyses are presented for the compounds not yet described. The dissociation constants of these model substances have been measured potentiometrically in pyridine, dimethylformamide, methanol, ethanol, propylene carbonate, acetone, acetonitrile, 1,2-dichloroethane and tetramethylene sulfone. The pKHA values obtained have been correlated with three sets of the Hammett substituent constants and the results have been used to discuss the solvent and substituent effects on the dissociation of the compounds studied. Sulfonimides with electron-acceptor substituents behave as rather strong acids in some solvents (pyridine, dimethylformamide, methanol and ethanol), whereas normal substituent dependences are found in other solvents. The experimental data have also been interpreted with the help of the statistical methods based on latent variables. From the calculations it follows that only the first principal component, which correlates well with the substituent constant sets adopted, is statistically significant in describing the substituent effect on the acid-base process studied.

    已合成了十种一般公式为XC6H4SO2NHSO2C6H4X的4,4'-二取代双(芳烃磺酰)亚胺,并通过它们的1H核磁共振谱确认了它们的结构。对尚未描述的化合物进行了元素分析。这些模型物质的解离常数已在吡啶、二甲基甲酰胺、甲醇、乙醇、丙烯碳酸酯、丙酮、乙腈、1,2-二氯乙烷和四亚甲基砜中电位测定。获得的pKHA 值已与三组Hammett取代基常数相关联,并利用结果讨论了溶剂和取代基对所研究化合物解离的影响。在某些溶剂中(如吡啶、二甲基甲酰胺、甲醇和乙醇),具有电子受体取代基的磺酰亚胺表现为相当强的酸,而在其他溶剂中发现了正常的取代基依赖性。实验数据还通过基于潜在变量的统计方法进行了解释。计算结果表明,仅第一个主成分与所采用的取代基常数集相关,对所研究的酸碱过程的取代基效应具有统计学意义。
  • [EN] NOVEL IODINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND USE THEREOF AS AMINATION AGENTS<br/>[FR] NOUVEAUX COMPOSÉS D'IODE, PROCÉDÉS POUR LEUR PRÉPARATION ET UTILISATION DE CEUX-CI EN TANT QU'AGENTS D'AMINATION
    申请人:FUNDACIO PRIVADA INST CATALA D INVESTIGACIO QUIMICA ICIQ
    公开号:WO2012160112A1
    公开(公告)日:2012-11-29
    The iodine compounds of the present invention corresponds to those of formula (I), wherein R1, R1' and X have several meanings. These iodine compounds gives rise to the amination of several substrates without the need of catalysts, especially metal catalysts, and confer to the amination reaction the further advantage of being performed under mild conditions, which is of interest for industrial-scale production of nitrogenated compounds with pharmaceutical, biological or medicinal applications. Therefore, the iodine compounds of the invention are useful as amination agents. The invention also discloses several processes for the preparation of the iodine compounds of formula (I).
    本发明的碘化合物对应于式(I)的化合物,其中R1、R1'和X具有多种含义。这些碘化合物使得多种底物的氨基化反应无需催化剂,特别是金属催化剂,并且赋予氨基化反应在温和条件下进行的进一步优势,这对于在工业规模生产具有药用、生物学或药用应用的氮化合物方面是有利的。因此,本发明的碘化合物可用作氨基化试剂。该发明还揭示了几种制备式(I)的碘化合物的方法。
  • Electrochemical selective annulative amino-ketalization and amino-oxygenation of 1,6-enynes
    作者:Xiao-Shuang Ji、Hang-Dong Zuo、Yi-Ting Shen、Wen-Juan Hao、Shu-Jiang Tu、Bo Jiang
    DOI:10.1039/d2cc03922b
    日期:——
    A new electrochemical selective annulative amino-ketalization and amino-oxygenation of 1,6-enynes with disulfonimides and alcohols is reported, producing a series of functionalized benzofurans under catalyst- and oxidant-free conditions. The annulative aminoketalization proceeds with simple short-chain alcohols such as methanol, ethanol and n-propanol as O-nucleophilic reagents, while the reaction occurs
    报道了一种新的电化学选择性环氨基缩酮化和 1,6-烯炔与二磺酰亚胺和醇的氨基氧化反应,在无催化剂和无氧化剂的条件下产生了一系列功能化的苯并呋喃。环氨基缩酮化以简单的短链醇如甲醇、乙醇和正丙醇作为O亲核试剂进行,而反应在水和大空间仲丁醇 (SBA) 存在下沿环氨基氧化方向进行。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐